Henry Schein Reshapes Leadership Team, 3 Execs to Exit

Henry Schein announced that it’s creating the Henry Schein Leadership Team (HSLT) to replace its existing Executive Management Committee. The company will also integrate its global supply chain organization with its global distribution group.

In accordance with the new HSLT, executive VP and COO Michael Ettinger, executive VP and chief strategy officer Mark Mlotek, and senior VP of global supply chain Jim Mullins will depart from their positions on October 30. After this date, the trio will remain as senior advisors.

The company appointed Fred Lowery as its new CEO earlier this year, and he took office on March 2. He succeeded Stanley Bergman, who stepped down after a 35-year CEO tenure and 45 years total with the company.

Henry Schein said it’s confident the new leadership structure will continue to develop its strategic priorities, accelerate execution, and enhance enterprise collaboration.

Comments from Henry Schein execs

Fred Lowery, CEO: “I am pleased to announce a new leadership structure at Henry Schein that reflects an important evolution of our organization designed to help Henry Schein become simpler, prioritize and make decisions faster, better execute on our priorities, and become an even more customer-centric organization. I am pleased to announce a new leadership structure at Henry Schein that reflects an important evolution of our organization designed to help Henry Schein become simpler, prioritize and make decisions faster, better execute on our priorities, and become an even more customer-centric organization.

Over their decades with Henry Schein, the wide-ranging impact made by Michael, Mark, and Jim upon our company, the healthcare industry, and patient health globally is impossible to quantify. Through his strategic vision and forging of partnerships over 30+ years, Mark played an integral role in growing Henry Schein from a small, privately-held mostly dental mail-order company into a multi-billion dollar public company that is the world’s largest provider of health care products, services, and technology platforms to office-based health care professionals. Similarly, I want to recognize Michael and Jim for helping build Henry Schein’s global corporate, legal, and supply chain infrastructure and, together, developing a world class team that today stands as a true competitive advantage. In their new senior advisory roles, we are fortunate to continue benefiting from their invaluable experience, insights, and strategic guidance as we execute our strategy and position the company for continued success.

William Daniel, board chairman: “Henry Schein owes a debt of gratitude to Michael, Mark, and Jim for the significant impact of their contributions to Henry Schein’s growth across more than 100 years of combined experience with the Company, during which they have each served as pillars for the organization whose unique vision, dedication, and authentic reflection of Henry Schein’s values helped to create the tremendous platform upon which we continue to build.”

Philip Laskawy, director and former lead director: “Their outstanding judgment, strategic perspective, and unwavering dedication have made an extraordinary impact upon Henry Schein. It was a privilege to serve alongside Mark on the Board, and we are deeply grateful to Mark and Michael for their enduring contributions to our Board, the company’s leadership team, and our stakeholders.”